Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q2 EPS of ($0.31), $0.11 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
- Cisco Systems (CSCO) Tops Q4 EPS by 5c; offers guidance
- Fossil Group (FOSL) Tops Q2 EPS by 9c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
